Is Exponent, Inc. (EXPO) A Good Stock To Buy Now?
Is EXPO a good stock to buy? We came across a bullish thesis on Exponent, Inc. on X.com by @tomicki. In this article, we will summarize the bulls’ thesis on EXPO.
Exponent Inc (EXPO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 1,323,097 | $77,745,180 | +16% | 0.63% |
| 2. | AQR Capital Management Cliff Asness | 1,144,847 | $67,271,185 | +17% | 0.02% |
| 3. | Point72 Asset Management Steve Cohen | 394,502 | $23,180,938 | 0.03% | |
| 4. | Millennium Management Israel Englander | 391,047 | $22,977,922 | -25% | 0.01% |
| 5. | BAMCO Inc. Ron Baron | 364,297 | $21,406,092 | -27% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.64 | 89 | $5,931.18 | 29,581 | 2026-01-02 | Filing | |
| $63.75 | 80 | $5,099.60 | 29,492 | 2025-10-03 | Filing | |
| $73.25 | 80 | $5,859.60 | 29,412 | 2025-07-04 | Filing | |
| $73.21 | 67 | $4,904.87 | 31,332 | 2025-04-04 | Filing | |
| $84.46 | 61 | $5,152.33 | 28,693 | 2025-01-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.28 | 1,707 | $113,135.86 | 129,108 | 2026-08-17 | Filing | |
| $62.78 | 1,737 | $109,044.69 | 115,771 | 2026-07-15 | Filing | |
| $57.13 | 1,793 | $102,427.46 | 107,257 | 2026-06-15 | Filing | |
| $57.13 | 2,326 | $132,875.77 | 106,670 | 2026-06-15 | Filing | |
| $57.47 | 2,000 | $114,930.00 | 1,105 | 2026-05-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,184,950 | $363,427,646 | 0.01% | |
| 2. | 3,995,684 | $234,786,416 | 0.73% | |
| 3. | 3,143,624 | $184,719,346 | 0.01% | |
| 4. | 2,180,212 | $128,109,257 | 0% | |
| 5. | 1,943,646 | $114,208,639 | 0% |
News See All
Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Exponent, Inc. Fourth Quarter and Fiscal Year 2025 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded.
Exponent, Inc. (NASDAQ:EXPO) Q1 2026 Earnings Call Transcript
Operator: Good afternoon. My name is Jeannie, and I will be your conference operator today.
Truist Maintains Buy Rating on Exponent (EXPO) While Cutting Price Target to $90
On November 2, Truist lowered its price target for Exponent, Inc. (NASDAQ:EXPO) from $100 to $90 while maintaining a Buy rating, according to a report by The Fly.
15 Overlooked Dividend Stocks to Buy Right Now
A report by Thornburg Investment Management noted that, unlike bond interest payments that stay fixed for the bond’s duration, cash dividends paid to equity shareholders can grow over time.
Exponent, Inc. (NASDAQ:EXPO) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the Exponent, Inc. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Exponent (EXPO) Tumbled as Guidance Fell Short of Expectations
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter 2025 investor letter.
What Makes Exponent (EXPO) a Compelling Short Opportunity?
Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here.
Exponent, Inc. (NASDAQ:EXPO) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to Exponent Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Should You Hold Exponent (EXPO) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.